$ELVR

Elevra Lithium Ltd (ASX:ELV) Binding Agreement Concluded with Mangrove Lithium

Elevra Lithium (ASX:ELV) has signed a binding 7-year spodumene supply agreement with Mangrove Lithium, extendable for another 7 years. The deal secures long-term local supply for Elevra's Quebec operations at market-linked prices with downside protection. Mangrove's facility, pending financing, will avoid Elevra's ocean freight costs. Both companies are backed by Canada Growth Fund.

Original reporting
Published Aug 24, 2026, 2:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 2:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Elevra Lithium Ltd (ASX:ELV) Binding Agreement Concluded with Mangrove Lithium — source image
Decision brief

The 30-second read

$ELVRBullishMed
01

Why it matters

The deal provides Elevra with a stable revenue stream, price floor protection, and reduced logistics costs, likely supporting its valuation.

02

Market read

First‑report of a material supply contract that could positively affect Elevra's share price and the broader North American lithium sector.

03

What to watch

Financing risk for Mangrove's conversion plant and potential delays in FID could affect contract execution.

Relevance 7/10Novelty 7/10Timing: announced today

Background

Elevra Lithium (NASDAQ:ELVR) secured a seven‑year supply agreement with Mangrove Lithium for spodumene concentrate from its North American Lithium project in Quebec.

Company-level read

Ticker impact

$ELVRBullishHigh confidence
Context

Elevra Lithium announced a binding Spodumene Concentrate Supply Agreement with Mangrove Lithium, securing long‑term off‑take and price floor.

Expected impact

Potential upside as market price for spodumene may rise; floor price above cost supports margins.

Evidence & confidence

New multi‑year supply deal with volume up to 144,000 dmt and no price ceiling gives Elevra exposure to price upside and reduces freight costs.

Market effects

Strengthens North American lithium supply chain, may benefit other battery‑material producers.

Boosts Canadian lithium sector confidence with Canada Growth Fund backing.

Adds to global lithium supply security, could influence lithium pricing trends.

Counterpoint

If market spodumene prices fall, the floor may limit upside and the contract could become a cost drag.

Key entities

  • Elevra Lithium Ltd

    North American lithium producer listed on NASDAQ (ELVR).

  • Mangrove Lithium

    Private lithium refining technology firm developing a conversion facility in Eastern Canada.

Related articles

$CCJMed

Long-Term Uranium Price Moves Past Its 2007 Peak While Energy Metals Deals Keep Coming

Uranium prices hit new highs, with long-term contracts at $96.50/lb and spot at $89.63/lb, according to Cameco. Despite this, uranium equities like Cameco (CCJ) and the VanEck Uranium ETF (NLR) have declined. Policy support for nuclear energy grew, with a U.S.-Korea framework for reactor deployment. Lithium prices also rose, with Chinese battery-grade lithium carbonate averaging 122,350 yuan/tonne.

$ELVRMedAI 8/10

Elevra Lithium Provides Ewoyaa Sale Update

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) updates on the sale of its Ewoyaa Lithium Project to Zhejiang Huayou Cobalt. The deal, valued at ~$71M, awaits Ghanaian government approval. If not secured by Oct 30, 2026, Huayou can pay a $5M break fee or terminate. Huayou also received FIRB approval for its acquisition of Atlantic Lithium, which holds the remaining private-sector interest in Ewoyaa.

$ELVRMedAI 8/10

Elevra fires up NAL lithium mine expansion

Elevra Lithium (ASX: ELV, Nasdaq: ELVR) has begun a $366M expansion of its North American Lithium mine in Quebec, aiming to nearly double production to 373,000 tonnes of spodumene concentrate by 2029. The project, funded by equity and convertible notes, is expected to reduce costs and secure customers through price-protected offtake agreements, including a deal with Mangrove Lithium.

$ELVRMed

Elevra Lithium Announces NAL Expansion Pre-Feasibility Study

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) announced a Pre-Feasibility Study for its North American Lithium (NAL) expansion in Québec. The study projects increased annual spodumene concentrate production to 373ktpa, reduced unit costs, and a post-tax NPV of C$3,218M. The expansion is fully funded with C$366M in initial CAPEX and will be delivered in three stages, starting mid-2027.